Skip to main content
Clinical Trials/NCT03948750
NCT03948750
Completed
Not Applicable

Comparison of Immunoblotting (IgA and IgG) and the Goldmann-Witmer Coefficient for Diagnosis of Ocular Toxoplasmosis in Immunocompetent Patients

Hospices Civils de Lyon1 site in 1 country87 target enrollmentJanuary 1, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ocular Toxoplasmosis
Sponsor
Hospices Civils de Lyon
Enrollment
87
Locations
1
Primary Endpoint
Comparison of Goldmann-Witmer coefficient and immunoblotting results
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Ocular toxoplasmosis (OT) is a common cause of posterior uveitis worldwide. The diagnosis of OT is based on clinical findings, but in most cases, laboratory tests are required to confirm the etiology, especially when other diseases are suspected. The aim of this study was to evaluate which methods, between the Goldmann-Witmer coefficient (GWC) and immunoblotting (IB) with both IgG and IgA, in aqueous humour (AH) samples, can be the most sensitive to diagnose OT, in current practice, especially in the first three weeks.

Detailed Description

Goldmann-Witmer coefficient (GWC): compares the levels of intraocular antibody (igG) production to that serum, as measured by ELISA. GWC = (Level of specific IgG in aqueous humour/level of specific IgG in serum)/(Total IgG in aqueous humour/Total IgG in serum) 0.5 to 2: No intraocular antibody production, 2 to 4: Suggestive of intraocular antibody production, \> 4: Diagnostic of intraocular antibody production to a specific microbial pathogen

Registry
clinicaltrials.gov
Start Date
January 1, 2010
End Date
May 31, 2014
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who had underwent aqueous humor and serum sample for ocular toxoplasmosis diagnosis

Exclusion Criteria

  • Immunocompromised patients

Outcomes

Primary Outcomes

Comparison of Goldmann-Witmer coefficient and immunoblotting results

Time Frame: Assessment of each test result at the inclusion of the patient

All tests realized in patients were performed before their repartition in the two groups as well as the biologist could not know the status of the patient. Sensitivity and specificity were calculated for each test.

Study Sites (1)

Loading locations...

Similar Trials